ClinicalTrials.gov
ClinicalTrials.gov Menu

The Effects of the Direct Acting Antiviral Agent Boceprevir on the Pharmacokinetics of Maraviroc in Healthy Volunteers

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
ClinicalTrials.gov Identifier: NCT01627717
Recruitment Status : Completed
First Posted : June 26, 2012
Last Update Posted : January 26, 2018
Sponsor:
Collaborators:
Université de Montréal
McGill University Health Center
Toronto General Hospital
Information provided by (Responsible Party):
Nancy Sheehan, Centre hospitalier de l'Université de Montréal (CHUM)

No Study Results Posted on ClinicalTrials.gov for this Study
  Recruitment Status : Completed
  Actual Primary Completion Date : April 2013
  Actual Study Completion Date : February 2014